We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
182 hedge funds and large institutions have $1.64B invested in Esperion Therapeutics in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 66 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
76% more capital invested
Capital invested by funds: $930M → $1.64B (+$710M)
74% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 23
61% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 41
34% more call options, than puts
Call options by funds: $47.6M | Put options by funds: $35.5M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more funds holding
Funds holding: 165 → 182 (+17)
7.37% more ownership
Funds ownership: 108.38% → 115.76% (+7.4%)
Holders
182
Holders Change
+17
Holders Change %
+10.3%
% of All Funds
3.73%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
40
Increased
66
Reduced
41
Closed
23
Calls
$47.6M
Puts
$35.5M
Net Calls
+$12.1M
Net Calls Change
+$16.5M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$26.8M |
| 2 |
Millennium Management
New York
|
+$18.6M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$14.8M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$14.1M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$11.1M |
Top Sellers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.35M |
| 2 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$7.02M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.91M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.96M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.56M |
